Apollo Hospitals stock last stood at INR 7,775.00 with P/ E 53.5

Published on 10/12/2026 at 13:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Apollo Hospitals stock stood at INR 7,775.00 on October 12, 2026. The P/E was 53.5 and the 52-week high was INR 9,070.50.

Key points in brief

Apollo Hospitals stock stood at INR 7,775.00 on October 12, 2026, with a P/E ratio of 53.5.
First-quarter fiscal 2027 revenue reached INR 70.44 billion against consensus of INR 68.86 billion.
Jefferies set a target of INR 10,350 on October 1, 2026, while regulatory pricing proposals remain a sector risk.

Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals Enterprise Limited, identified by Global Banking & Finance as APOLLOHOSP.NS on the NSE under ISIN INE437A01024, was last quoted at INR 7,775.00 on October 12, 2026 at 3:29 p.m. IST. The P/E ratio was 53.51, placing valuation alongside a 52-week range of INR 6,696.50 to INR 9,070.50.

Price sits below yearly high

The stock was 14.28 percent below its 52-week high and 16.10 percent above its 52-week low, calculated from the same NSE quote. Trading volume reached 990,733 shares against an average volume of 421,971, while market capitalization stood at INR 1.1 trillion.

That positioning gives the price report a clear numerical frame: Apollo Hospitals remains above its yearly floor, but the quote is below the upper end of its range. The P/E of 53.51 is also higher than the comparable multiples shown for Max Healthcare and Medanta.

First-quarter revenue beats consensus

Investing.com listed Apollo Hospitals earnings for the quarter ended June 2026 on August 12, 2026. Revenue reached INR 70.44 billion against consensus of INR 68.86 billion, while earnings per share came to INR 40.40 versus consensus of INR 39.02.

The revenue comparison represents a 2.29 percent beat against consensus, and earnings per share exceeded the estimate by 3.54 percent. These figures give the current valuation a recent operating reference without turning the price report into a forecast.

Comparison with peers

Apollo Hospitals (NSE, INR): , P/E 53.51, market capitalization INR 1.1 trillion
Max Healthcare (NSE, INR): minus 2.02 percent, P/E 58.08, market capitalization INR 842.8 billion
Medanta (NSE, INR): minus 0.25 percent, P/E 63.32, market capitalization INR 352.1 billion

Target remains above the quote

Business Today reported on October 1, 2026 that Jefferies set a target of INR 10,350 for Apollo Hospitals. That target lies 33.12 percent above the NSE price of INR 7,775.00. The same report cited regulatory concerns over consumable and oncology drug pricing and estimated a 2.00-5.00 percent potential impact on earnings before interest, taxes, depreciation and amortization under different price-cap scenarios.

Current NSE quote

Apollo Hospitals was last at INR 7,775.00 on the NSE on October 12, 2026 at 3:29 p.m. IST, with a 52-week high of INR 9,070.50 and a 52-week low of INR 6,696.50. The P/E ratio was 53.51 and market capitalization was INR 1.1 trillion.